Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Induction treatment of newly diagnosed Multiple Myeloma eligible for autologous stem cell transplant.
Anaplastic Oligodendroglioma and low-grade 1p/19q-codeleted Gliomas following radiation.
Disseminated non-seminomatous testicular cancer and ovarian germ cell neoplasms.
Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Ovarian Cancer, Kaposi Sarcoma, and Lymphomas.
Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Ovarian Cancer, Kaposi Sarcoma, and Lymphomas.
Myelofibrosis, Polycythemia Vera, and acute/chronic Graft-versus-Host Disease (GVHD).
Hodgkin Lymphoma, CD30-expressing T-cell lymphomas, Urothelial Carcinoma, Cervical Cancer, or Diffuse Large B-cell Lymphoma.
HR-positive, HER2-negative advanced, metastatic, or high-risk early Breast Cancer.
Approved for use in oncology care according to FDA-approved indications.
Prevention and management of chemotherapy-induced and radiation-induced nausea and vomiting (CINV).
Prevention and management of chemotherapy-induced and radiation-induced nausea and vomiting (CINV).
Prevention of skeletal-related events in patients with bone metastases from solid tumors and multiple myeloma; hypercalcemia of malignancy.